fbpx

IBgen IVF. A genetic study of ovarian reserve

The analysis of genes associated with ovarian reserve enables us to not only make diagnoses, but also to determine the most appropriate medication for each patient

IBgen IVF. A genetic study of ovarian reserve

  • Wilt u meer informatie ontvangen?

    Wij geven u vrijblijvend advies

  • DD slash MM slash JJJJ
  • Dit veld is bedoeld voor validatiedoeleinden en moet niet worden gewijzigd.

When a couple tries to get pregnant but it does not happen, in many cases, this may be due to ovarian reserve. In those cases in which ovarian reserve is poor and/or of poor quality, getting a larger number of eggs can be the key to success.

Our research has centred around searching for the genes involved in ovarian reserve with a view to not only making a diagnosis but also to determining the medication to which the patient responds best. This can help improve the prognosis and achieve an increased and improved ovarian response. Instituto Bernabeu Biotech is an international leader in progress in pharmacogenetics within the field of reproductive medicine, having made publications in prestigious scientific magazines and given presentations of its most relevant research in the most significant congresses for this speciality.

Identified the genes involved in ovarian reserve

Personalized treatment plan

Pharmacogenetics: higher response medication

Higher number of eggs

What is the IBgen IVF test?

Using a simple saliva or blood test, our team studies the genetic variants which we have determined and verified are involved in ovarian response.

We analyse the genetic variant within the FSH receptor gene, the androgen receptor and the ESR1 (SNP y STRs) and AMHR2 genes.

Along with other markers, the genotype means we are able to determine how a patient will respond with a great deal of precision, before treatment has begun. This favours the process of determining the most suitable line of medication for the patient, using the gonadotropins that will generate an optimum response and adjusting the dose to the genotype.

It also evaluates genetic risk factors on ovarian reserve and means the patient can be made aware, in advance, of the possible issues surrounding poor ovarian response.

What advantages are there to the IBgen IVF test?

  • It identifies the genetic cause behind poor ovarian response and it not only provides a diagnosis but also the treatment. Based on genetic counselling, it determines the most suitable medication for optimising ovarian response.
  • It increases the efficiency of the treatment of the assisted reproduction technique.
  • Getting an in-depth understanding of the pathology reduces the anxiety and emotional stress which is understandably associated with patients who have reproduction issues.

When is it advisable to have the IBgen IVF test?

  • Any patient who is a poor responder and who wishes to undergo an in-depth diagnosis of their pathology in order to have their genotype and receive the treatment programme to which they will respond the best.
  • Any patient searching for the medication which best suits their genetic make-up before undergoing in vitro fertilisation.
  • Any patient who, whether for personal interest or as a result of family or medical precedents, wishes to know if she will suffer from poor ovarian reserve in the future. This can help when planning for motherhood.

What is the scientific basis for the IBgen IVF study?

We have carried out prior research on over 300 patients and 400 ovarian stimulation cycles in order to analyse the role the genotype plays in ovarian response in patients who undergo treatment with gonadotropins.

We have also evaluated the prevalence of those variants in patients with poor ovarian response.

Our results show that these variants can be used as a factor in prediction and diagnosis of poor ovarian reserve. Variants in the FSH gene receptor may also be used in order to determine the most suitable dose and gonadotropin for ovarian stimulation in the patient.

This pharmacogenetic approach means that IVF treatment may be individualised and optimised and the patient can be provided with information on why she is a poor responder and the risks of this happening again in the future.

Published scientific research carried out by Instituto Bernabeu which supports the scientific evidence of the IBgen IVF study.  

IBgen FIV. Estudio genético de la reserva ovárica
IBgen FIV. Estudio genético de la reserva ovárica

Scientific research presented in national and international congresses which supports the scientific evidence of the IBgen IVF study.

Laten we praten

Wij adviseren u vrijblijvend

Neem contact op